Following the recent approval of TissuePatch™ in China, Tissuemed is pleased to announce that the company will be attending the forthcoming meeting of the Chinese Neurosurgical Society, being held in Lanzhou, 8-10 September.
“With more than 3,000 delegates expected to participate from across China, this is an excellent opportunity for Tissuemed®, in collaboration with our local partners, to launch the TissuePatch™ range to the Chinese neurosurgical community.We look forward to engaging with surgeons and demonstrating how TissuePatch™ can be used for dural closure to seal and reinforce, so CSF leaks are prevented and post-operative complications eliminated” commented Dr David Mandley, Tissuemed’s CEO.For further information on TissuePatch for dural sealing, click here or contact us directly via sales@tissuemed.com